Research Article
Predictive Value of Plasma MicroRNA-216a/b in the Diagnosis of Esophageal Squamous Cell Carcinoma
Table 1
Clinicopathologicalcharacteristics of patients with ESCC.
| Characteristics | (%) | Plasma miRNA-718 expression (mean ± SD) | miR-216a | value | miR-216b | value |
| Age (year) | | | 0.1082 | | 0.2125 | ≤63 | 46 (38.3) | 0.058 ± 0.048 | | 0.079 ± 0.086 | | >63 | 74 (61.7) | 0.074 ± 0.054 | | 0.099 ± 0.087 | | Gender | | | 0.5388 | | 0.5912 | Male | 79 (65.8) | 0.070 ± 0.055 | | 0.094 ± 0.087 | | Female | 41 (34.2) | 0.064 ± 0.048 | | 0.085 ± 0.089 | | Smoking | | | 0.1342 | | 0.6168 | Never | 52 (43.3) | 0.060 ± 0.047 | | 0.087 ± 0.079 | | Ever | 68 (56.7) | 0.074 ± 0.056 | | 0.095 ± 0.093 | | Alcohol use | | | 0.2378 | | 0.5386 | Never | 40 (33.3) | 0.060 ± 0.054 | | 0.098 ± 0.087 | | Ever | 80 (66.7) | 0.072 ± 0.051 | | 0.088 ± 0.087 | | Tumor location | | | 0.3136 | | 0.1810 | Upper esophagus | 11 (9.2) | 0.065 ± 0.061 | | 0.106 ± 0.092 | | Middle esophagus | 70 (58.3) | 0.074 ± 0.056 | | 0.100 ± 0.096 | | Low esophagus | 39 (32.5) | 0.058 ± 0.041 | | 0.072 ± 0.066 | | Histologic grade | | | 0.8959 | | 0.8308 | Well differentiated | 33 (27.5) | 0.070 ± 0.059 | | 0.109 ± 0.112 | | Moderately differentiated | 70 (58.3) | 0.068 ± 0.052 | | 0.089 ± 0.082 | | Poorly differentiated | 17 (14.2) | 0.063 ± 0.040 | | 0.068 ± 0.030 | | T stage | | | 0.3206 | | 0.6600 | Tis-T1 | 36 (30.0) | 0.075 ± 0.061 | | 0.115 ± 0.114 | | T2 | 28 (23.3) | 0.086 ± 0.065 | | 0.100 ± 0.090 | | T3 | 41 (34.2) | 0.056 ± 0.037 | | 0.074 ± 0.065 | | T4 | 15 (12.5) | 0.050 ± 0.019 | | 0.067 ± 0.031 | | Lymph node metastasis | | | 0.0845 | | 0.0168 | Negative | 42 (35.0) | 0.088 ± 0.068 | | 0.134 ± 0.117 | | Positive | 78 (65.0) | 0.057 ± 0.038 | | 0.068 ± 0.054 | | TNM stage | | | 0.0054 | | 0.0359 | 0-I | 29 (24.2) | 0.088 ± 0.062 | | 0.134 ± 0.119 | | II | 28 (23.3) | 0.086 ± 0.065 | | 0.101 ± 0.090 | | III | 40 (33.3) | 0.058 ± 0.035 | | 0.072 ± 0.067 | | IV | 23 (19.2) | 0.039 ± 0.022 | | 0.060 ± 0.029 | |
|
|